United Therapeutics: approves $2,000,000,000 share repurchase program

What happened On Oct 21, 2026, the Board of Directors of United Therapeutics Corporation approved a share repurchase program authorizing the purchase by the Company of up to $2,000,000,000 of the Company’s common stock. On Oct 22, 2026, the Company issued a press release announcing the Share Repurchase Program.

Key details

• authorized amount: $2,000,000,000 of common stock
• authorization period: 1-year period ending Oct 21, 2027
• board approval date: Oct 21, 2026
• press release announcing the program issued Oct 22, 2026

Why it may matter Item 8.01 (other events) was reported; Item 8.01 covers the Company’s approval and announcement of the share repurchase program described above. This filing does not show why the insider traded or why the company acted.